Initiated Phase 2 Seabreeze STAT Asthma and Seabreeze STAT COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations in Asthma and COPD in May 2025; topline data expected in ...

For World Asthma Day, GINA released its 2025 guidelines update and joined in a campaign to make inhaled asthma therapies more ...

Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 – SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect ...

Your doctor or dietitian can advise you on managing your weight by following a customized eating plan and an achievable exercise program. Learn more about the relationship between weight and COPD.

The GOLD classification is used to determine COPD severity and help form a treatment plan. This is based on ... The GOLD guidelines for COPD management recommend phosphodiesterase-4 inhibitors ...

“Identifying COPD early can lead to more aggressive management strategies ... mortality risk in this population,” Fu said. “We plan to explore the role of inflammation, shared risk factors ...

Nottinghamshire Healthcare’s community respiratory nurses are excited to pilot a brand new programme for patients with newly diagnosed Chronic Obstructive Pulmonary Disease (COPD), living in Mansfield ...

In Singapore, Dupixent is the first biologic medicine approved to treat these COPD patients. The prevalence of COPD is estimated to be around 6% of the general population [1], and it ranks as a ...

Expect to report topline data from the Seabreeze STAT Asthma study in 1H 2026 – – On track to initiate similarly-designed Phase 2 study in patients with COPD imminently S ...

India reportedly has the highest asthma-related deaths in the world, accounting for nearly 46% of them. With over 34 million ...

Pulmatrix, Inc. ("Pulmatrix" or the "Company") , a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and ...